title: Performance of screening mammography in organized programs in Canada in 1996. The Database Management Subcommittee to the National Committee for the Canadian Breast Cancer Screening Initiative.
abstract: BACKGROUND
  The results of randomized trials show that breast cancer screening by mammography reduces breast cancer mortality by up to 40% in women aged 50-69 years. Because of these results, by 1998, 22 countries, including Canada, had established population-based organized screening programs. This paper presents the results of screening mammography in 1996 for 7 provincially organized breast cancer screening programs in Canada.
  
  
  METHODS
  Analyses of interim performance indicators for screening mammography have been calculated from data submitted to the Canadian Breast Cancer Screening database. The data set consisted of data from 7 provincial programs and was limited to mammographic screens for women aged 50-69 years (n = 203,303). Screening outcomes and performance indicators were calculated for abnormalities detected by screening mammography only.
  
  
  RESULTS
  The abnormal recall rate was 9.5% for first screens and 4.6% for subsequent screens, and the cancer detection rate per 1000 women screened was 6.9 for first screens and 3.8 for subsequent screens. The positive predictive value (i.e., the proportion of women who tested positive by mammography who were found to have breast cancer on screen-initiated diagnostic work-up) increased from 7.2% at the first screen to 8.2% at subsequent screens. Estimated participation rates within organized programs varied from 10.6% to 54.2%, depending on the province.
  
  
  CONCLUSIONS
  For 1996, organized breast cancer screening programs met or exceeded many of the interim measures used in international programs. It is possible to translate the benefits of breast cancer screening by mammography, as demonstrated in randomized trials, into population-based community programs. Screening mammography through organized programs should increase to allow more comprehensive monitoring in Canada.
authors.affiliation: Centre for Chronic Disease Prevention and Control (Formerly the Laboratory Centre for Disease Control), Health Canada, Ottawa, Ont.
authors.forename: D
authors.initials: D
authors.lastname: Paquette
authors.forename: J
authors.initials: J
authors.lastname: Snider
authors.forename: F
authors.initials: F
authors.lastname: Bouchard
authors.forename: I
authors.initials: I
authors.lastname: Olivotto
authors.forename: H
authors.initials: H
authors.lastname: Bryant
authors.forename: K
authors.initials: K
authors.lastname: Decker
authors.forename: G
authors.initials: G
authors.lastname: Doyle
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000401:mortality*; D002170:Canada; D003431:Cross-Cultural Comparison; D005260:Female; D006801:Humans; D008327:Mammography; D008403:Mass Screening; D008875:Middle Aged; D009313:National Health Programs; D015996:Survival Rate